FindTrial
Sign In

Effect of transversus abdominis plane block in lower segment caesarean section with comparative study of efficacy and safety of bupivacaine and ropivacaine.

A comparative study of efficacy and safety of transversus abdominis plane block with bupivacaine and ropivacaine for post-operative analgesia following lower segment caesarean section:A prospective, randomized, controlled, double blind study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/034633
Enrollment
100
Registered
2021-07-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O82- Encounter for cesarean delivery without indication

Interventions

Intervention1: inj Bupivacaine 0.25% in transversus abdominis plane block in spinal anesthesia.: Transversus abdominis plane block using Bupivacaine 0.25% 15ml+15ml bilaterally at petit triangle is gi

Sponsors

JLN Medical college Ajmer
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant patients between 20years -35 years Informed consent for participation in study ASA physical 1& 2 Elective or non-urgent lower segment caesarean section

Exclusion criteria

Exclusion criteria: Age less than 20 years and above 35 years Patients not willing to participate in the study Any hypersensitivity or contraindication to local anaesthetics Patient with chronic pain or on long-term analgesics contraindication to spinal anaesthesia like local infection at the site of lumbar puncture,any bleeding disorders like thrombocytopenia,space occupying lesion of the brain,anatomical disorders of the spine,hypovolemia

Design outcomes

Primary

MeasureTime frame
Comparison of number and frequency of post operative analgesia required in both the groups for first 24h postoperatively to assess the effective analgesia by visual analog scale (VAS) scoreTimepoint: 1 year—

Secondary

MeasureTime frame
To assess and compare the hemodynamic changes. To assess and compare the proportion of patients having adverse effect and other complication.Timepoint: Around 1 year—

Countries

India

Contacts

Public ContactDr Veena Patodi

JLN Medical college Ajmer

veenapatodi@gmail.com941408276

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026